SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-018653
Filing Date
2020-07-07
Accepted
2020-07-07 18:57:30
Documents
1
Period of Report
2020-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12054
  Complete submission text file 0000899243-20-018653.txt   14722
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Issuer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address UNTERMATTWEG 8 BERNE V8 CH-3027
Business Address UNTERMATTWEG 8 BERNE V8 CH-3027 41 58 852 81 11
Vifor Pharma Ltd. (Reporting) CIK: 0001416422 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35420 | Film No.: 201016923

Mailing Address RECHENSTRASSE 37 ST. GALLEN V8 9000
Business Address RECHENSTRASSE 37 ST. GALLEN V8 9000 41 58 851 80 00
Vifor (International) Ltd (Reporting) CIK: 0001675217 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35420 | Film No.: 201016922

Mailing Address RECHENSTRASSE 37 CH-9014 ST. GALLEN V8 9014
Business Address RECHENSTRASSE 37 CH-9014 ST. GALLEN V8 9014 0041588518051
Vifor Fresenius Medical Care Renal Pharma Ltd. (Reporting) CIK: 0001757924 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35420 | Film No.: 201016924